A VGF-derived peptide attenuates development of type 2 diabetes via enhancement of islet β-cell survival and function

Cell Metabolism

Volumn 16, Issue 1, 2012, Pages 33-43

  Stephens, Samuel B ^a   Schisler, Jonathan C ^a   Hohmeier, Hans E ^a   An, Jie ^a   Sun, Albert Y ^a   Pitt, Geoffrey S ^a   Newgard, Christopher B ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; EXENDIN 4; GLUCAGON LIKE PEPTIDE 1; TLQP 21; TRANSCRIPTION FACTOR NKX6.1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; GLUCOSE TOLERANCE; HUMAN; HUMAN CELL; IN VIVO STUDY; INSULIN RELEASE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STOMACH EMPTYING;

ANIMALS; APOPTOSIS; AREA UNDER CURVE; BLOOD GLUCOSE; CELL SURVIVAL; CELLS, CULTURED; CYCLIC AMP; DIABETES MELLITUS, TYPE 2; GASTRIC EMPTYING; GENE EXPRESSION; GLUCOSE; HEART RATE; HOMEODOMAIN PROTEINS; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN-SECRETING CELLS; MALE; NEUROPEPTIDES; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR; TRANS-ACTIVATORS;

RATTUS;

EID: 84863515698     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2012.05.011     Document Type: Article

References (43)

1. B. Ahrén, J.J. Holst, H. Mårtensson, and B. Balkan Improved glucose tolerance and insulin secretion by inhibition of dipeptidyl peptidase IV in mice Eur. J. Pharmacol. 404 2000 239 245
2. J.M. Barragán, R.E. Rodríguez, and E. Blázquez Changes in arterial blood pressure and heart rate induced by glucagon-like peptide-1-(7-36) amide in rats Am. J. Physiol. 266 1994 E459 E466
3. A. Bartolomucci, G. La Corte, R. Possenti, V. Locatelli, A.E. Rigamonti, A. Torsello, E. Bresciani, I. Bulgarelli, R. Rizzi, and F. Pavone TLQP-21, a VGF-derived peptide, increases energy expenditure and prevents the early phase of diet-induced obesity Proc. Natl. Acad. Sci. USA 103 2006 14584 14589
4. A. Bartolomucci, E. Bresciani, I. Bulgarelli, A.E. Rigamonti, T. Pascucci, A. Levi, R. Possenti, A. Torsello, V. Locatelli, E.E. Muller, and A. Moles Chronic intracerebroventricular injection of TLQP-21 prevents high fat diet induced weight gain in fast weight-gaining mice Genes Nutr 4 2009 49 57
5. C. Cocco, C. Brancia, I. Pirisi, F. D'Amato, B. Noli, R. Possenti, and G.L. Ferri VGF metabolic-related gene: distribution of its derived peptides in mammalian pancreatic islets J. Histochem. Cytochem. 55 2007 619 628
6. M. Cornu, J.Y. Yang, E. Jaccard, C. Poussin, C. Widmann, and B. Thorens Glucagon-like peptide-1 protects beta-cells against apoptosis by increasing the activity of an IGF-2/IGF-1 receptor autocrine loop Diabetes 58 2009 1816 1825
7. M. Cornu, H. Modi, D. Kawamori, R.N. Kulkarni, M. Joffraud, and B. Thorens Glucagon-like peptide-1 increases beta-cell glucose competence and proliferation by translational induction of insulin-like growth factor-1 receptor expression J. Biol. Chem. 285 2010 10538 10545
8. C.F. Deacon, A.H. Johnsen, and J.J. Holst Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo J. Clin. Endocrinol. Metab. 80 1995 952 957
9. D.J. Drucker, and M.A. Nauck The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes Lancet 368 2006 1696 1705
10. I.B. Efanova, S.V. Zaitsev, B. Zhivotovsky, M. Köhler, S. Efendić, S. Orrenius, and P.O. Berggren Glucose and tolbutamide induce apoptosis in pancreatic beta-cells. A process dependent on intracellular Ca2+ concentration J. Biol. Chem. 273 1998 33501 33507
11. G.L. Ferri, A. Levi, and R. Possenti A novel neuroendocrine gene product: selective VGF8a gene expression and immuno-localisation of the VGF protein in endocrine and neuronal populations Brain Res. Mol. Brain Res. 13 1992 139 143
12. D.T. Finegood, M.D. McArthur, D. Kojwang, M.J. Thomas, B.G. Topp, T. Leonard, and R.E. Buckingham Beta-cell mass dynamics in Zucker diabetic fatty rats. Rosiglitazone prevents the rise in net cell death Diabetes 50 2001 1021 1029
13. A.L. Garcia, S.K. Han, W.G. Janssen, Z.Z. Khaing, T. Ito, M.J. Glucksman, D.L. Benson, and S.R. Salton A prohormone convertase cleavage site within a predicted alpha-helix mediates sorting of the neuronal and endocrine polypeptide VGF into the regulated secretory pathway J. Biol. Chem. 280 2005 41595 41608
14. N.H. Greig, H.W. Holloway, K.A. De Ore, D. Jani, Y. Wang, J. Zhou, M.J. Garant, and J.M. Egan Once daily injection of exendin-4 to diabetic mice achieves long-term beneficial effects on blood glucose concentrations Diabetologia 42 1999 45 50
15. S. Hahm, T.M. Mizuno, T.J. Wu, J.P. Wisor, C.A. Priest, C.A. Kozak, C.N. Boozer, B. Peng, R.C. McEvoy, and P. Good Targeted deletion of the Vgf gene indicates that the encoded secretory peptide precursor plays a novel role in the regulation of energy balance Neuron 23 1999 537 548
16. S. Hatanaka, M. Kondoh, K. Kawarabayashi, and K. Furuhama The measurement of gastric emptying in conscious rats by monitoring serial changes in serum acetaminophen level J. Pharmacol. Toxicol. Methods 31 1994 161 165
17. H. Hui, L. Farilla, P. Merkel, and R. Perfetti The short half-life of glucagon-like peptide-1 in plasma does not reflect its long-lasting beneficial effects Eur. J. Endocrinol. 146 2002 863 869
18. J.G. Hunsberger, S.S. Newton, A.H. Bennett, C.H. Duman, D.S. Russell, S.R. Salton, and R.S. Duman Antidepressant actions of the exercise-regulated gene VGF Nat. Med. 13 2007 1476 1482
19. P.H. Jethwa, A. Warner, K.N. Nilaweera, J.M. Brameld, J.W. Keyte, W.G. Carter, N. Bolton, M. Bruggraber, P.J. Morgan, P. Barrett, and F.J. Ebling VGF-derived peptide, TLQP-21, regulates food intake and body weight in Siberian hamsters Endocrinology 148 2007 4044 4055
20. U.S. Jhala, G. Canettieri, R.A. Screaton, R.N. Kulkarni, S. Krajewski, J. Reed, J. Walker, X. Lin, M. White, and M. Montminy cAMP promotes pancreatic beta-cell survival via CREB-mediated induction of IRS2 Genes Dev. 17 2003 1575 1580
21. S.E. Kahn, S.M. Haffner, M.A. Heise, W.H. Herman, R.R. Holman, N.P. Jones, B.G. Kravitz, J.M. Lachin, M.C. O'Neill, B. Zinman, G. Viberti ADOPT Study Group Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy N. Engl. J. Med. 355 2006 2427 2443
22. T.J. Kieffer, C.H. McIntosh, and R.A. Pederson Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV Endocrinology 136 1995 3585 3596
23. A. Levi, G.L. Ferri, E. Watson, R. Possenti, and S.R. Salton Processing, distribution, and function of VGF, a neuronal and endocrine peptide precursor Cell. Mol. Neurobiol. 24 2004 517 533
24. K. Maedler, R.D. Carr, D. Bosco, R.A. Zuellig, T. Berney, and M.Y. Donath Sulfonylurea induced beta-cell apoptosis in cultured human islets J. Clin. Endocrinol. Metab. 90 2005 501 506
25. D.M. Muoio, and C.B. Newgard Mechanisms of disease: molecular and metabolic mechanisms of insulin resistance and beta-cell failure in type 2 diabetes Nat. Rev. Mol. Cell Biol. 9 2008 193 205
26. F. Ovalle, and D.S. Bell Clinical evidence of thiazolidinedione-induced improvement of pancreatic beta-cell function in patients with type 2 diabetes mellitus Diabetes Obes. Metab. 4 2002 56 59
27. R. Possenti, A.M. Rinaldi, G.L. Ferri, P. Borboni, E. Trani, and A. Levi Expression, processing, and secretion of the neuroendocrine VGF peptides by INS-1 cells Endocrinology 140 1999 3727 3735
28. R. Possenti, G. Muccioli, P. Petrocchi, C. Cero, A. Cabassi, L. Vulchanova, M.S. Riedl, M. Manieri, A. Frontini, and A. Giordano Characterization of a novel peripheral pro-lipolytic mechanism in mice: role of VGF-derived peptide TLQP-21 Biochem. J. 441 2012 511 522
29. M.K. Reimer, J.J. Holst, and B. Ahrén Long-term inhibition of dipeptidyl peptidase IV improves glucose tolerance and preserves islet function in mice Eur. J. Endocrinol. 146 2002 717 727
30. S.R. Salton Nucleotide sequence and regulatory studies of VGF, a nervous system-specific mRNA that is rapidly and relatively selectively induced by nerve growth factor J. Neurochem. 57 1991 991 996
31. S.R. Salton, D.J. Fischberg, and K.W. Dong Structure of the gene encoding VGF, a nervous system-specific mRNA that is rapidly and selectively induced by nerve growth factor in PC12 cells Mol. Cell. Biol. 11 1991 2335 2349
32. J.C. Schisler, P.B. Jensen, D.G. Taylor, T.C. Becker, F.K. Knop, S. Takekawa, M. German, G.C. Weir, D. Lu, R.G. Mirmira, and C.B. Newgard The Nkx6.1 homeodomain transcription factor suppresses glucagon expression and regulates glucose-stimulated insulin secretion in islet beta cells Proc. Natl. Acad. Sci. USA 102 2005 7297 7302
33. J.C. Schisler, P.T. Fueger, D.A. Babu, H.E. Hohmeier, J.S. Tessem, D. Lu, T.C. Becker, B. Naziruddin, M. Levy, R.G. Mirmira, and C.B. Newgard Stimulation of human and rat islet beta-cell proliferation with retention of function by the homeodomain transcription factor Nkx6.1 Mol. Cell. Biol. 28 2008 3465 3476
34. C. Severini, G. La Corte, G. Improta, M. Broccardo, S. Agostini, C. Petrella, V. Sibilia, F. Pagani, F. Guidobono, and I. Bulgarelli In vitro and in vivo pharmacological role of TLQP-21, a VGF-derived peptide, in the regulation of rat gastric motor functions Br. J. Pharmacol. 157 2009 984 993
35. D.A. Stoffers, T.J. Kieffer, M.A. Hussain, D.J. Drucker, S. Bonner-Weir, J.F. Habener, and J.M. Egan Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas Diabetes 49 2000 741 748
36. M. Szayna, M.E. Doyle, J.A. Betkey, H.W. Holloway, R.G. Spencer, N.H. Greig, and J.M. Egan Exendin-4 decelerates food intake, weight gain, and fat deposition in Zucker rats Endocrinology 141 2000 1936 1941
37. E. Trani, A. Giorgi, N. Canu, G. Amadoro, A.M. Rinaldi, P.A. Halban, G.L. Ferri, R. Possenti, M.E. Schininà, and A. Levi Isolation and characterization of VGF peptides in rat brain. Role of PC1/3 and PC2 in the maturation of VGF precursor J. Neurochem. 81 2002 565 574
38. A.N. van den Pol, C. Decavel, A. Levi, and B. Paterson Hypothalamic expression of a novel gene product, VGF: immunocytochemical analysis J. Neurosci. 9 1989 4122 4137
39. Q. Wang, L. Li, E. Xu, V. Wong, C. Rhodes, and P.L. Brubaker Glucagon-like peptide-1 regulates proliferation and apoptosis via activation of protein kinase B in pancreatic INS-1 beta cells Diabetologia 47 2004 478 487
40. E. Watson, S. Hahm, T.M. Mizuno, J. Windsor, C. Montgomery, P.E. Scherer, C.V. Mobbs, and S.R. Salton VGF ablation blocks the development of hyperinsulinemia and hyperglycemia in several mouse models of obesity Endocrinology 146 2005 5151 5163
41. E. Watson, S. Fargali, H. Okamoto, M. Sadahiro, R.E. Gordon, T. Chakraborty, M.W. Sleeman, and S.R. Salton Analysis of knockout mice suggests a role for VGF in the control of fat storage and energy expenditure BMC Physiol. 9 2009 19
42. G. Xu, D.A. Stoffers, J.F. Habener, and S. Bonner-Weir Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats Diabetes 48 1999 2270 2276
43. H. Yamamoto, C.E. Lee, J.N. Marcus, T.D. Williams, J.M. Overton, M.E. Lopez, A.N. Hollenberg, L. Baggio, C.B. Saper, D.J. Drucker, and J.K. Elmquist Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons J. Clin. Invest. 110 2002 43 52